# Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

> **NCT03501576** · — · RECRUITING · sponsor: **Emory University** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

## Interventions

- **BIOLOGICAL:** Inactivated Influenza Vaccine

## Key facts

- **NCT ID:** NCT03501576
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-04-06
- **Primary completion:** 2026-05-26
- **Final completion:** 2026-05-26
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03501576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03501576, "Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03501576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*